Grail is a healthcare company that develops pan-cancer screening tests designed to detect cancers at an early stage.
Grail has raised $325.0M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in October 2025.
Grail's investors include HSG, Samsung Electronics, SV Angel, ARCH Venture Partners, Hillhouse Investment.
Grail is headquartered in Menlo Park, United States.
Grail is a healthcare company that develops pan-cancer screening tests designed to detect cancers at an early stage.
Grail is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Grail — Funding & Investors." VCBacked, October 20, 2025, https://www.vcbacked.co/company/grail. Accessed November 12, 2026.
VCBacked. (2025). Grail — Funding & Investors. Retrieved November 12, 2026, from https://www.vcbacked.co/company/grail
{{cite web |title=Grail — Funding & Investors |url=https://www.vcbacked.co/company/grail |website=VCBacked |access-date=November 12, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated
Work at Grail? Request a listing update